Spondyloarthritis study: Etanercept vs Benzathine Penicillin
Official title Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis
ClinicalTrials.gov ID: NCT06707194
What this study is testing
What is Etanercept?
This is an investigational injectable medicine being studied as a potential treatment for spondyloarthritis. It is designed to block a protein in the body called tumor necrosis factor (TNF) that can cause inflammation.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study checks if combining an antibiotic with a standard arthritis treatment is safe and works better than the standard treatment alone.
- Who it's for
- The study is looking for adults who have spondyloarthritis, a type of arthritis that affects the spine and joints.
- What's involved
- Participants will receive either the combination of the antibiotic and the arthritis drug, or just the arthritis drug. They will have regular check-ups to track their symptoms, health, and safety.
- Time commitment
- The source text does not specify the total duration of the study or the exact number of visits required.
- Phase 4: studies an already-approved treatment
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 59
You may be able to join if
- The following patients would be included: (1) The people voluntarily participate and sign an informed consent form; (2) patients aged 18-59 years
You likely can't join if
- he exclusion criteria are as follows: (1) people with nasopharyngitis, active tuberculosis, inflammatory bowel disease and other infections, other...
The study team makes the final eligibility decision.
Where it is enrolling
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Guangzhou, Guangdong, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.